Stocks · Health care · In Vitro & In Vivo Diagnostic Substances

Intellia Therapeutics, Inc.

NTLA Clue Score53
United States Fiscal year ends December CIK 0001652130 Results filed 5 Nov 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
John M Leonard
11 Dec 2025
President and CEO
Sold after exercise
5,355
$9.59
$51.35K
John M Leonard
11 Dec 2025
President and CEO
Sold after exercise
32,832
$9.47
$310.92K
John M Leonard
11 Dec 2025
President and CEO
Sold after exercise
49,959
$9.49
$474.11K

What was left out

Form 4 filings counted 30
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 4
Sales straight out of an exercise 3
Sales at will 12
Transactions with no price 0
Shares from compensation/vesting 660,244
History held since 9 May 2016